Caribbean Pharmaceutical Policy
MetadataShow full item record
[Executive Summary]. Every human being is entitled to the enjoyment of the highest attainable standard of health conducive to living in dignity. Access to health care, which includes access to essential medicines, is a prerequisite for realising that right. National medicines expenditures, as a proportion of total health expenditures, currently range from 7% to 66% worldwide. In the Caribbean, the implementation of the Revised Treaty of Chaguaramas and the establishment of the CARICOM Single Market and Economy (CSME) provide a favourable environment for regional integration. However, there are challenges in the area of health, given the health situation, geography, limited human resources and continued migration. At the same time, the tourism sector is being challenged by poor sanitation, untreated sewage that may damage beaches, food-borne disease outbreaks in public places, the threat of natural disasters and the need to mount an effective, rapid response to manage and control epidemics. There is a need to focus on achieving a strong, comprehensive and integrated public health response through health environment strategies that address these priority areas. Recognising the challenge of ensuring sustained access to adequate quality medicines at affordable prices, the CARICOM Ministers of Health, at the Tenth Meeting of the Council for Human and Social Development (COHSOD) (April 2003), mandated the establishment of a Technical Advisory Group (TAG) on Trade-Related Intellectual Property Rights (TRIPS). TAG, by means of a regional assessment of drug regulatory and registration systems and a regional assessment of patent and related issues and access to medicines in CARICOM countries and the Dominican Republic, sought to assess the current situation and to propose solutions for improving the situation with respect to medicines. Complementary to these studies, PAHO/WHO published a report on the pharmaceutical situation in the Caribbean in 2007, with the participation of 13 Caribbean countries. At the Eighteenth Meeting of the Caucus of CARICOM Health Ministers, held in 2009 in Washington, D.C., the ministers supported an accelerated approach to a series of projects related to improving quality of life, establishing partnerships in pharmaceutical policies, addressing intellectual property rights, and strengthening the functions of the health sector, among others. The Caucus also urged that there be coordinated collaboration among the Chief Medical Officers (CMOs), the CARICOM Health Desk and PAHO on the issue.
Showing items related by title, author, creator and subject.
Preston, Charles; King, Claire; Hinds, Maryam; Burnett, Francis; Extavour, Rian Marie (2021-05-07)[ABSTRACT]. Objective. To examine multiple aspects of the medicines in CARICOM procurement markets, including manufacturer headquarters location, regulatory history, and type (innovator versus generic); the proportion of ...
The 2007 Caribbean Community Port-of-Spain Declaration on noncommunicable diseases: an overview of a multidisciplinary evaluation Samuels, T. Alafia; Unwin, Nigel (2018-12)[ABSTRACT]. Objectives. Noncommunicable diseases (NCDs) are a threat to social and economic development, including in the Caribbean. In 2007 the Caribbean Community (CARICOM) held the world’s firstever summit of heads of ...
Pan American Health Organization (Washington, D.C, PAHO, 2010)[Preface]. This Factbook is part of an effort to collect, systematize and make available information about the pharmaceutical situation in the countries of the Caribbean. The data is compared with the entire Region of ...